We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00955292
Recruitment Status : Terminated (Modified dose schedule presented no advantage over previously studied schedule)
First Posted : August 10, 2009
Last Update Posted : August 10, 2009
Sponsor:
Information provided by:
Cylene Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2008
  Study Completion Date : December 2008